These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31122130)
1. MiR-150-5p retards the progression of myocardial fibrosis by targeting Shen J; Xing W; Gong F; Wang W; Yan Y; Zhang Y; Xie C; Fu S Cell Cycle; 2019 Jun; 18(12):1335-1348. PubMed ID: 31122130 [TBL] [Abstract][Full Text] [Related]
2. The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model. Song CL; Liu B; Diao HY; Shi YF; Li YX; Zhang JC; Lu Y; Wang G; Liu J; Yu YP; Guo ZY; Wang JP; Zhao Z; Liu JG; Liu YH; Liu ZX; Cai D; Li Q Int J Mol Sci; 2014 Sep; 15(10):17442-56. PubMed ID: 25268616 [TBL] [Abstract][Full Text] [Related]
3. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells. Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323 [TBL] [Abstract][Full Text] [Related]
4. Hepatic miR-181b-5p Contributes to Glycogen Synthesis Through Targeting EGR1. Wang S; Liang C; Ai H; Yang M; Yi J; Liu L; Song Z; Bao Y; Li Y; Sun L; Zhao H Dig Dis Sci; 2019 Jun; 64(6):1548-1559. PubMed ID: 30627917 [TBL] [Abstract][Full Text] [Related]
5. MiR-467a-5p aggravates myocardial infarction by modulating ZEB1 expression in mice. Huang W; Cao Y; Chen C; Wu X; Sheng Z; Li A J Mol Histol; 2021 Aug; 52(4):767-780. PubMed ID: 33997926 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats. Wang G; Wang R; Ruan Z; Liu L; Li Y; Zhu L Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32885809 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-140-5p targeting tumor necrosis factor-α prevents pulmonary arterial hypertension. Zhu TT; Zhang WF; Yin YL; Liu YH; Song P; Xu J; Zhang MX; Li P J Cell Physiol; 2019 Jun; 234(6):9535-9550. PubMed ID: 30367500 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics prediction and experimental verification of a novel microRNA for myocardial fibrosis after myocardial infarction in rats. Guo Q; Wu D; Jia D; Zhang X; Wu A; Lou L; Zhao M; Zhao M; Gao Y; Wang M; Liu M; Chen M; Zhang D PeerJ; 2023; 11():e14851. PubMed ID: 36788811 [TBL] [Abstract][Full Text] [Related]
9. The crosstalk of HDAC3, microRNA-18a and ADRB3 in the progression of heart failure. Na J; Jin H; Wang X; Huang K; Sun S; Li Q; Zhang W Cell Biosci; 2021 Feb; 11(1):31. PubMed ID: 33549119 [TBL] [Abstract][Full Text] [Related]
10. microRNA-181c-5p stimulates the development of coronary artery disease by targeting SIRT1. Ma C; Zheng X; Wu X; Cheng J; Zhang K Hellenic J Cardiol; 2023; 69():31-40. PubMed ID: 36243396 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats. He J; Lu Y; Song X; Gong X; Li Y Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31763669 [TBL] [Abstract][Full Text] [Related]
12. LncRNA ANRIL-mediated miR-181b-5p/S1PR1 axis is involved in the progression of uremic cardiomyopathy through activating T cells. Xu Y; Cao L; Ji S; Shen W Sci Rep; 2022 Oct; 12(1):18027. PubMed ID: 36302829 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy Zhang Y; Ding Y; Li M; Yuan J; Yu Y; Bi X; Hong H; Ye J; Liu P Acta Pharm Sin B; 2022 May; 12(5):2374-2390. PubMed ID: 35646533 [TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis. Li J; Xu C; Liu Y; Li Y; Du S; Zhang R; Sun Y; Zhang R; Wang Y; Xue H; Ni S; Asiya M; Xue G; Li Y; Shi L; Li D; Pan Z; Zhang Y; Wang Z; Cai B; Wang N; Yang B Basic Res Cardiol; 2020 Jan; 115(2):9. PubMed ID: 31900593 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma. Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931 [TBL] [Abstract][Full Text] [Related]
16. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1. Zhao TF; Wang SY; Zou XZ; Zhao HD Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy. Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837 [TBL] [Abstract][Full Text] [Related]
18. miR-192 prevents renal tubulointerstitial fibrosis in diabetic nephropathy by targeting Egr1. Liu F; Zhang ZP; Xin GD; Guo LH; Jiang Q; Wang ZX Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4252-4260. PubMed ID: 30024615 [TBL] [Abstract][Full Text] [Related]
19. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction. Li J; Cai SX; He Q; Zhang H; Friedberg D; Wang F; Redington AN Basic Res Cardiol; 2018 Aug; 113(5):36. PubMed ID: 30084039 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-326-5p enhances therapeutic potential of endothelial progenitor cells for myocardial infarction. Li X; Xue X; Sun Y; Chen L; Zhao T; Yang W; Chen Y; Zhang Z Stem Cell Res Ther; 2019 Nov; 10(1):323. PubMed ID: 31730013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]